AsclepiX Therapeutics has filed a notice of an exempt offering of securities to raise $12,544,498.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, AsclepiX Therapeutics is raising up to $12,544,498.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Robert Dempsey played a…
